FDA reviews cardiac risk of Invirase in combination with Norvir - ONA

Links shared publicly online about this topic.

  • 1,360
    total visits

FDA reviews cardiac risk of Invirase in combination with Norvir - ONA

oncologynurseadvisor.com

The FDA has notified healthcare professionals and patients that it is reviewing clinical trial data about a potentially serious effect on the heart associated with the use of Invirase (saquinavir, from Roche) in combination with Norvir (ritonavir, from Abbott).

View full resource at oncologynurseadvisor.com

Tags: Heart, HIV Medication, Healthcare, Clinical Trial, FDA, Norvir, Invirase

  • Share

Most Recently Shared on February 23, 2010 at 9:09 pm By:

ONAcom OncologyNurseAdvisor

FDA reviews cardiac risk of Invirase in combination with Norvir http://goo.gl/fb/DyEy

2 years ago...

Symposier - Review of HIV medication Invirase (saquinavir) and Cardiac Arrhythmias

symposier.com — “Uploaded and Shared in Youtube by: USFoodandDrugAdmin FDA is reviewing clinical trial data suggesting that using Invirase (saquinavir) in combination with Norvir (ritonavir) may increase the risk of cardiac arrhythmias. Invirase and Norvir are protease inhibitors used in combination to treat HIV infection. The study was conducted by Roche, the manufacturer of Invirase, in response to FDA's request that all manufacturers of protease inhibitors evaluate the effect of these drugs on QT and PR View full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on May 24, 2010 at 10:17 pm By:

SympoCardiology Symposier Cardiology Cardiology and Health Business

Review of HIV medication Invirase (saquinavir) and Cardiac Arrhythmias. http://bit.ly/9rZAqS

2 years ago...

FDA reviews cardiac risk of Invirase in combination with Norvir - MPR

empr.com — “The FDA has notified healthcare professionals and patients that it is reviewing clinical trial data about a potentially serious effect on the heart associated with the use of Invirase (saquinavir, from Roche) in combination with Norvir (ritonavir, from Abbott).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on February 23, 2010 at 9:07 pm By:

eMPR MPR Medical Publisher

MPR News: FDA reviews cardiac risk of Invirase in combination with Norvir: The FDA has notified healthcare profess... http://bit.ly/bNJGxD

2 years ago...

FDA Flags Safety Concern for HIV Drug Combination - WSJ.com

online.wsj.com — “The FDA said it was reviewing clinical data that suggest the HIV drug Invirase, given in combination with another HIV drug, Norvir, could cause heart problems.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on February 23, 2010 at 5:47 pm By:

Advertisement